Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of an Intensified Treatment Monitoring Strategy to Prevent Accumulation and Spread of HIV-1 Drug Resistance in Low- and Middle-income Countries (ITREMA).

NCT03357588 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT03357588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03357588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of an Intensified Treatment Monitoring Strategy to Prevent Accumulation and Spread of HIV-1 Drug Resistance in Low- and Middle-income Countries (ITREMA).
Lead sponsor
UMC Utrecht
Phase
Not applicable
Overall status
Completed
Start date
June 29, 2015
Completion date
May 31, 2022
Enrollment
501 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv/aids